Zobrazeno 1 - 10
of 52
pro vyhledávání: '"C. Udata"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of clinical pharmacology. 51(3)
The population pharmacokinetics of pantoprazole was characterized in pediatric patients from birth to 16 years using NONMEM and evaluated via bootstrap and predictive check. Data were described using a 2-compartment model with a typical parameterized
Autor:
J, Di Paola, M P, Smith, R, Klamroth, P M, Mannucci, C, Kollmer, J, Feingold, C, Kessler, H, Pollmann, M, Morfini, C, Udata, C, Rothschild, C, Hermans, R, Janco
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 13(2)
ReFacto is a recombinant B-domain-deleted, monoclonal antibody-purified, solvent-detergent-treated factor VIII (BDDrFVIII) with no albumin added to the final formulation. Although ReFacto has been shown to be bioequivalent to a plasma-derived FVIII p
Publikováno v:
Journal of pharmaceutical sciences. 89(6)
Cosalane is a potent inhibitor of HIV replication with activity against a broad range of viral targets. However, the oral bioavailability of this highly lipophilic compound is extremely poor (1%). Also, cosalane accumulates in high concentration in t
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 28(4)
Cosalane and dihydrocosalane are potent inhibitors of HIV replication with a broad range of activity. The purpose of this study was to investigate: 1) the pharmacokinetic disposition of both cosalane and dihydrocosalane in male Sprague-Dawley rats, a
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 27(8)
Cosalane is a potent inhibitor of HIV replication with a broad range of activity. In this study, the hepatic disposition of cosalane was investigated with a noncirculating isolated perfused rat liver technique. When 6 microM cosalane was infused into
Publikováno v:
Clinical Pharmacology & Therapeutics. 79:P50-P50
Publikováno v:
Clinical Pharmacology & Therapeutics. 79:P77-P77
Publikováno v:
Clinical Pharmacology & Therapeutics. 79:P25-P25
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.